Additional file 13 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer

Additional file 13. Survival analyses including luminal status. Reanalysis when also including luminal status in the (i) multivariable survival analysis, (ii) single-locus survival analysis, and (iii) risk score for the multi-locus signature.

附加文件13：包含腔面状态（luminal status）的生存分析。本次重新分析在（i）多变量生存分析、（ii）单基因座生存分析以及（iii）多基因座特征的风险评分三类分析中，均纳入腔面状态（luminal status）开展分析。